Masimo announced today that it initiated the full U.S. market release for its Stork home baby monitoring system. Stork offers a continuous and accurate view of a baby’s health data. It leverages Masimo’s noninvasive neonate monitoring technologies. The Irvine, California-based company kicked off its initial launch for the system in May of this year. “We […]
Masimo
Masimo ‘disappointed’ in Q2 results, confirms slashed guidance
Masimo shares fell this morning after the company shared second-quarter results that included reduced 2023 guidance. Shares of MASI were down more than 2% at $117.11 apiece. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down slightly. The guidance cut comes as no surprise after the […]
Masimo SedLine could improve brain monitoring during endoscopy, study says
Masimo today announced positive study findings from an evaluation of its SedLine brain function monitoring. Dr. Lichy Han and colleagues at Stanford University evaluated SedLine, publishing their findings in Frontiers in Neuroscience. They looked at SedLine’s ability to assess the sedation levels of patients undergoing drug-induced sleep endoscopy (DISE) with dexmedetomidine. Irvine, California-based Masimo said […]
Masimo expects to cut 2023 healthcare sales guidance by $150M, aims to reduce costs
Masimo announced preliminary second-quarter results that include a potentially significant reduction in sales guidance. Full-year guidance for Masimo’s healthcare business, previously set at $1.45 billion at the low end, is expected to be slashed to $1.3 billion. The company also said yesterday that it is still evaluating the upper end of its guidance, which could […]
Masimo loses board seats to activist investor Politan
Masimo shareholders voted to oust two members of the device developer’s board after a heated battle by activist investor Politan Capital Management. Masimo has yet to release official results, but acknowledged defeat today in a statement to MassDevice. “We are disappointed to have lost the valuable contributions of two very qualified and capable board […]
ISS backs Politan’s nominees in Masimo board battle; Device developer says CEO is the target
Politan Capital Management’s fight for two Masimo board seats won a key endorsement from proxy advisory firm Institutional Shareholder Services (ISS), the activist investor said today. ISS is recommending Masimo shareholders vote for Politan’s two board nominees: Politan Managing Partner and Chief Investment Officer Quentin Koffey and former Johnson & Johnson MedTech executive Michelle Brennan. […]
Masimo wins FDA clearance for wearable vital sign monitor
Masimo (Nasdaq:MASI) announced today that the FDA cleared its Radius VSM patient-worn, continuous, multi-parameter vital signs monitor. Radius VSM enables physicians to monitor a range of physiological measurements. That includes Masimo SET pulse oximetry, noninvasive blood pressure, temperature, respiration rate and ECG. Masimo said its monitor combines the reliability and accuracy of larger bedside monitors […]
New FDA clearance will boost Philips and Masimo partnership
Philips and Masimo today announced an FDA clearance that allows the incorporation of Masimo’s advanced monitoring tech into Philips’ existing high-acuity patient monitors. The FDA clearance allows the companies to use SedLine brain function monitoring, Regional Oximetry and CO2 measurements in Philips’ patient monitors, IntelliVue MX750 and MX850. This is the latest extension of Masimo […]
Masimo management trades blows with activist investor Politan
The fight for two seats on the Masimo board is heating up ahead of the medtech developer’s annual shareholder meeting next month. Masimo management and activist investor Politan Capital Management released dueling presentations over the last 24 hours in support of their respective director nominees. Previously: Masimo beats the Street in Q1 ahead of proxy […]
Masimo expands HEOS home monitoring platform
Masimo (Nasdaq:MASI) today announced the global expansion of its HEOS platform for always-on connection through its secure cloud. The Masimo Health secure cloud covers 4 million devices, offering customers an enhanced health-tracking experience. This software upgrade enables Masimo’s devices and cloud solution to seamlessly integrate with HEOS-enabled devices. Those include sound bars, wireless speakers, amplifiers […]
Masimo beats the Street in Q1 ahead of proxy fight; CEO discusses Apple mistrial
Masimo reported Street-beating first-quarter results and maintained its full-year 2023 guidance ahead of a proxy battle at the annual meeting of shareholders. Investors reacted by sending MASI shares up 1% to $186.50 apiece in after-hours trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was down slightly. The […]
